NeoPharm Co (XKRX:092730) Ending Cash Position : ₩11,881 Mil (As of Dec. 2023)

View and export this data going back to 2007. Start your Free Trial

What is NeoPharm Co Ending Cash Position?

NeoPharm Co's Ending Cash Position for the quarter that ended in Dec. 2023 was ₩11,881 Mil.

NeoPharm Co's quarterly Ending Cash Position declined from Jun. 2023 (₩17,288 Mil) to Sep. 2023 (₩11,513 Mil) but then increased from Sep. 2023 (₩11,513 Mil) to Dec. 2023 (₩11,881 Mil).

NeoPharm Co's annual Ending Cash Position increased from Dec. 2021 (₩7,049 Mil) to Dec. 2022 (₩10,883 Mil) and increased from Dec. 2022 (₩10,883 Mil) to Dec. 2023 (₩11,881 Mil).

NeoPharm Co Ending Cash Position Historical Data

The historical data trend for NeoPharm Co's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NeoPharm Co Ending Cash Position Chart

NeoPharm Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Ending Cash Position

Get a 7-Day Free Trial

5,515.26

11,188.73

7,048.98

10,882.86

11,880.93

NeoPharm Co Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Ending Cash Position	Get a 7-Day Free Trial															10,882.86	15,769.60	17,287.77	11,512.81	11,880.93

NeoPharm Co Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

NeoPharm Co's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	10882.863	+	998.062
	=	11,881

NeoPharm Co's Ending Cash Position for the quarter that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	11512.806	+	368.119
	=	11,881

NeoPharm Co Ending Cash Position Related Terms

Thank you for viewing the detailed overview of NeoPharm Co's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

NeoPharm Co (XKRX:092730) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » NeoPharm Co Ltd (XKRX:092730) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

N/A

Address

928 Tamnip-dong, Yuseong-gu, Daejon, KOR, 305-510

Website

http://www.neopharm.co.kr

NeoPharm Co Ltd is a South Korean company operating in the household and personal products. The products of the company include skin care brand, skin barrier special dermo cosmetic brand, hospital functional products, and life moisturizing body professional brand.

NeoPharm Co (XKRX:092730) Headlines

No Headlines